FDA Clearance Tracker · P030016-S049
Visian® Toric Implantable Collamer® Lens (TICL)
Last checked: Nov 20, 2026Latest source record: Dec 10, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Dec 10, 2025
Approved
Time to decision
167 days
Received Jun 26, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track No User Fee
Device class
Class III
The decision
- FDA number
- P030016-S049
- Device name
- Visian® Toric Implantable Collamer® Lens (TICL)
- Applicant
- STAAR Surgical Company
- Applicant location
- Monrovia, CA
- Received
- Jun 26, 2025
- Decided
- Dec 10, 2025
- Decision
- Approved
- Supplement type
- Normal 180 Day Track No User Fee
- Reason for supplement
- Labeling Change - PAS
- Original approval
- P030016
Device type
- Device type
- Phakic toric intraocular lens (QCB)
- Device class
- Class III
- Regulation
- 21 CFR 886.3600
- Specialty
- Ophthalmology
FDA's approval statement
As written in FDA's record.
Approval for updates to labeling for the Visian® Toric Implantable Collamer Lens (TICL), EVO/EVO+ Visian® ICL, and EVO/EVO+ Visian® TICL to reflect the findings of the P030016/S001 PMA New Enrollment Post-Approval Study.
Source documents
Other decisions for STAAR Surgical Company
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- EVO/EVO+VISIAN Implantable Collamer LensPMA supplement
P030016-S035 · Decided Mar 25, 2022 · 1,240 days after receipt · Panel Track
Device type: Lens, intraocular, phakic (MTA) · Ophthalmology
3 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.